ECI Intelligence

Evidence-based publications for professionals, companies and investors in the European cannabis sector. White papers, regulatory commentary, case studies and industry intelligence β€” published by ECI practitioners.

πŸ“„
White Papers
βš–οΈ
Regulatory Commentary
πŸ”
Case Studies
πŸ“Š
Industry Intelligence
πŸ“‘
Regulatory Watch
πŸ₯
Medical Intelligence
πŸ“„
White Papers

In-depth guides solving specific GMP and compliance problems. Designed for QA managers, site directors and validation professionals who need practical, implementable guidance.

White Papers
A practical framework for assessing and building pharmaceutical-grade quality systems in licensed cannabis manufacturing operations.
πŸ• 8 min πŸ“… July 2026 Email required
Read publication β†’
White Papers
What inspectors look for, how to prepare your team, documentation requirements, common findings and how to avoid them.
πŸ• 7 min πŸ“… July 2026 Email required
Read publication β†’
White Papers
Risk-based EMPQ design, alert and action limit derivation, sampling location justification and excursion management.
πŸ• 7 min πŸ“… July 2026 Email required
Read publication β†’
βš–οΈ
Regulatory Commentary

ECI analysis of regulatory guidance, consultation documents and inspection trends. Not a repetition of the guidance β€” an explanation of what it means and what operators must do.

Regulatory Commentary
Analysis of the EMA Cannabis flos quality monograph β€” what it requires, what it means for operators and what gaps remain unaddressed.
πŸ• 5 min πŸ“… July 2026 Free
Read publication β†’
Regulatory Commentary
A practical explanation of the 2022 revision of EU GMP Annex 1, focusing on contamination control strategy requirements and what has changed for cannabis manufacturers.
πŸ• 5 min πŸ“… July 2026 Free
Read publication β†’
Regulatory Commentary
The revised quality risk management guideline β€” what changed, what the FMEA requirements mean in practice and how to apply QRM to cannabis manufacturing.
πŸ• 4 min πŸ“… July 2026 Free
Read publication β†’
πŸ”
Case Studies

Analysis of public inspection findings, regulatory enforcement actions and real-world compliance challenges. All cases sourced from publicly available regulatory records.

Case Studies
Detailed analysis of the FDA warning letter issued to Bailey's Wellness LLC for CBD product GMP and marketing violations β€” and what European operators must learn.
πŸ• 5 min πŸ“… July 2026 Free
Read publication β†’
Case Studies
Analysis of publicly available pharmaceutical inspection reports identifying the ten most frequently cited GMP deficiencies in cannabis and herbal medicinal product manufacturing.
πŸ• 7 min πŸ“… July 2026 Free
Read publication β†’
Case Studies
Disease claims versus evidence β€” analysis of the Holista Pet warning letter and its implications for cannabis product claims strategy in European regulated markets.
πŸ• 4 min πŸ“… July 2026 Free
Read publication β†’
πŸ“Š
Industry Intelligence

Data-driven analysis of the European cannabis market using publicly available regulatory, clinical and commercial data sources. Baseline intelligence for operators, investors and policy professionals.

Industry Intelligence
A structured overview of the European cannabis sector in 2026 β€” market size, licensed operators, prescribing volumes, GMP capacity and regulatory developments by country.
πŸ• 6 min πŸ“… July 2026 Email required
Read publication β†’
Industry Intelligence
Country-by-country analysis of medical cannabis programmes across 32 European markets β€” patient numbers, prescribing pathways, GMP requirements and market access.
πŸ• 6 min πŸ“… July 2026 Email required
Read publication β†’
Industry Intelligence
Analysis of licensed pharmaceutical cannabis manufacturing across Europe β€” facility count, GMP certification status, product types, capacity and emerging trends.
πŸ• 5 min πŸ“… July 2026 Email required
Read publication β†’
πŸ“‘
Regulatory Watch

Monthly regulatory intelligence covering EMA publications, national authority announcements, inspection findings and policy developments across European cannabis markets.

Regulatory Watch
Key regulatory developments in July 2026 β€” EMA publications, national authority announcements, inspection findings and policy developments affecting pharmaceutical cannabis.
πŸ• 4 min πŸ“… July 2026 Free
Read publication β†’
Regulatory Watch
Key regulatory developments in August 2026 β€” EMA publications, national authority announcements, new guidance and policy developments affecting pharmaceutical cannabis.
πŸ• 4 min πŸ“… July 2026 Free
Read publication β†’
πŸ₯
Medical Intelligence

Clinical evidence summaries and professional education content for healthcare professionals prescribing, dispensing or advising patients on medical cannabis.

Medical Intelligence
A structured review of clinical evidence for cannabis-based medicines in chronic pain conditions β€” trial quality, effect sizes, patient selection and prescribing considerations.
πŸ• 7 min πŸ“… July 2026 Free
Read publication β†’
Medical Intelligence
Pharmacology, mechanisms of action, therapeutic applications and safety considerations for the four main cannabinoids β€” written for clinical practitioners.
πŸ• 6 min πŸ“… July 2026 Free
Read publication β†’
Medical Intelligence
A systematic summary of adverse effects, contraindications and clinically significant drug interactions for cannabis-based medicines β€” for prescribers and pharmacists.
πŸ• 5 min πŸ“… July 2026 Free
Read publication β†’
Additional reading

More intelligence articles

Article
Investment Trends in European Cannabis
Capital flows, funding rounds and investment patterns shaping the European pharmaceutical cannabis sector.
Article
Common Regulatory Mistakes in European Cannabis
The recurring regulatory missteps that delay market entry and trigger enforcement action.
Article
The Future of Pharmaceutical Cannabis
Where the European pharmaceutical cannabis sector is heading over the next five years.
Article
Top 25 GMP Inspection Findings in Cannabis Manufacturing
A synthesis of recurring pharmaceutical inspection themes applied to cannabis-specific operations.
Article
European Medical Cannabis Market Report 2026
A comprehensive market analysis of the European medical cannabis sector.
Stay informed

ECI Intelligence β€” direct to your inbox

New white papers, regulatory commentary and industry intelligence published every month. Free subscription.